Agios Pharmaceuticals, Inc. (AGIO)

26.98 -0.23 (-0.85%) USD  |  NASDAQ  |  May 06, 16:00
26.97 -0.01 (-0.04%) Pre-Market: 20:00
More

Agios Pharmaceuticals SG&A Expense (TTM) : 187.06M for March 31, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AGIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biogen, Inc. 2.468B
Catalyst Pharmaceuticals, Inc. 171.18M
Eli Lilly & Co. 11.56B
Apellis Pharmaceuticals, Inc. 550.26M
Alnylam Pharmaceuticals, Inc. 1.293B